<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for MACK</title>
    <link />
    <description>Headlines for Merrimack Pharmaceuticals, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Commit To Buy Merrimack Pharmaceuticals At $5, Earn 30.7% Annualized</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11950843/1/commit-to-buy-merrimack-pharmaceuticals-at-5-earn-307-annualized.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 14 Jun 2013 12:21:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Innovative Biotech Companies With Promising Cancer Therapies</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1467241-3-innovative-biotech-companies-with-promising-cancer-therapies.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 29 May 2013 11:38:54 GMT</pubDate>
    </item>
    <item>
      <title>Merrimack's CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1438511-merrimack-s-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 15 May 2013 19:03:05 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Lows</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3561430/stocks-hitting-52-week-lows.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 06 May 2013 10:23:53 GMT</pubDate>
    </item>
    <item>
      <title>Predicting Biotech Stock Moves Using Top Consensus Picks By Legendary Fund Managers</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1403711-predicting-biotech-stock-moves-using-top-consensus-picks-by-legendary-fund-managers.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 05 May 2013 13:23:34 GMT</pubDate>
    </item>
    <item>
      <title>Merrimack Pharmaceuticals Getting Very Oversold (MACK)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11904543/1/merrimack-pharmaceuticals-getting-very-oversold-mack.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Wed, 24 Apr 2013 12:36:00 GMT</pubDate>
    </item>
    <item>
      <title>Merrimack Pharmaceuticals' Preclinical Research Shows MM-111 Restores Sensitivity To Chemotherapy An</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3485916/merrimack-pharmaceuticals-preclinical-research-shows-mm-111-restores-sensitivity-.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 10 Apr 2013 09:03:21 GMT</pubDate>
    </item>
    <item>
      <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130404-000445&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Thu, 04 Apr 2013 08:47:59 GMT</pubDate>
    </item>
    <item>
      <title>Merrimack's MM-121 Misses Endpoint in Non-Small Cell Lung Cancer Study</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130404-000440&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Thu, 04 Apr 2013 08:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Buy Hercules Tech Growth Capital Instead Of OCZ Tech</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1303231-buy-hercules-tech-growth-capital-instead-of-ocz-tech.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 27 Mar 2013 06:35:08 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi/MACK Candidate Progresses - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/95251/sanofi-mack-candidate-progresses.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 20 Mar 2013 16:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Why Merrimack Is Poised to Outperform</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/20/why-merrimack-is-poised-to-outperform/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 20 Mar 2013 15:02:00 GMT</pubDate>
    </item>
    <item>
      <title>Merrimack Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1274861-merrimack-pharmaceuticals-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 14 Mar 2013 15:31:05 GMT</pubDate>
    </item>
    <item>
      <title>Why These 4 Biotechs Could Be Next In Line To See Their Share Prices Rise</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1258761-why-these-4-biotechs-could-be-next-in-line-to-see-their-share-prices-rise.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 08 Mar 2013 08:09:21 GMT</pubDate>
    </item>
    <item>
      <title>Merrimack's CEO Presents at 33rd Annual Cowen &amp;amp; Co. Health Care Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1252251-merrimack-s-ceo-presents-at-33rd-annual-cowen-amp-co-health-care-conference-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 06 Mar 2013 14:24:05 GMT</pubDate>
    </item>
    <item>
      <title>3 Events Biotech Investors Need to Watch in 2013</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/13/3-events-biotech-investors-need-to-watch-in/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 13 Feb 2013 15:08:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Things to Watch at Merrimack</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/27/3-things-to-watch-at-merrimack/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 27 Dec 2012 13:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Here's What This $4 Billion Hedge Fund Has Been Buying</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/14/heres-what-this-4-billion-hedge-fund-has-been-buyi/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 14 Dec 2012 19:55:00 GMT</pubDate>
    </item>
    <item>
      <title>1 Catalyst Biotech Investors Need to Watch</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/13/1-catalyst-biotech-investors-need-to-watch-2/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 13 Dec 2012 15:43:00 GMT</pubDate>
    </item>
    <item>
      <title>'Mad Money' Lightning Round: Buy, Buy, Buy Cabella's, UnitedHealthcare</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11786893/1/mad-money-lightning-round-buy-buy-buy-cabellas-unitedhealthcare.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Mon, 10 Dec 2012 06:00:00 GMT</pubDate>
    </item>
  </channel>
</rss>
